CONTRACT OPPORTUNITY

Toxicological Evaluations of Potential Medications to Treat Drug Abuse   3

Type: Special Notice • ID: 75N95023R00019

DESCRIPTION

The purpose of this amendment # 01 is to clarify the RFP requirements by responding to questions submitted. Please see the attached Amendmend 01 for more information.

Show All

OVERVIEW

Agency
National Institute on Drug Abuse (NIDA) [HHS - NIH]
Response Deadline
April 3, 2023, 2:00 p.m. EST Due in 14 Days
Posted
March 17, 2023, 11:09 a.m. EST
Set Aside
None
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN11 - Health R&D Services; Health Care Services; Basic Research
Place of Performance
USA
Source
SAM
Pricing
Multiple Types Common
On 3/17/23 National Institute on Drug Abuse issued Special Notice 75N95023R00019 for Toxicological Evaluations of Potential Medications to Treat Drug Abuse due 4/3/23.
PRIMARY CONTACT
Name
Polina Klimenkova   Profile
Email
polina.klimenkova@nih.gov
Phone
(301) 827-6848

SECONDARY CONTACT

Name
Joshua T. Lazarus   Profile
Email
josh.lazarus@nih.gov
Phone
(301) 827-6923

DOCUMENTS

Posted Documents for Special Notice 75N95023R00019

OPPORTUNITY LIFECYCLE

Procurement Notices Related to Special Notice 75N95023R00019

POTENTIAL BIDDERS

Awardees that Have Won Contracts Similar to Special Notice 75N95023R00019

SIMILAR ACTIVE OPPORTUNITIES

Open Contract Opportunities Similar to Special Notice 75N95023R00019

ADDITIONAL DETAILS

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NATIONAL INSTITUTES OF HEALTH NIDA
FPDS Organization Code
7529-75N950
Source Organization Code
100189048
Last Updated
March 17, 2023
Last Updated By
polina.klimenkova@nih.gov
Archive Date
March 17, 2023